Literature DB >> 6311972

Antiviral response of fibroblasts from familial Alzheimer's disease and Down's syndrome to human interferon-alpha.

S L Mowshowitz, G J Dawson, T S Elizan.   

Abstract

The relative sensitivities of human fibroblast cultures from patients with familial Alzheimer's disease (AD), patients with Down's syndrome (Trisomy 21, T-21), and normal control (D-21) subjects, to the antiviral effect of human interferon-alpha (Hu-IFN-alpha) were compared. In confirmation of previous studies, T-21 cell lines showed significantly enhanced sensitivities to IFN compared with D-21 cells from normal controls. Fibroblast cultures from 2 familial AD patients belonging to one family exhibited sensitivities which fell within the range of response of normal D-21 cells. In contrast, fibroblasts from two other related subjects, one with familial AD and his niece "at risk", were extremely insensitive to interferon.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6311972     DOI: 10.1007/bf01250054

Source DB:  PubMed          Journal:  J Neural Transm            Impact factor:   3.575


  13 in total

1.  Non-antiviral activities of interferon are not controlled by chromosome 21.

Authors:  E De Clercq; V G Edy; J Cassiman
Journal:  Nature       Date:  1975-07-10       Impact factor: 49.962

2.  Chromosome-21-dosage effect on inducibility of anti-viral gene(s).

Authors:  U H Tan
Journal:  Nature       Date:  1975-01-24       Impact factor: 49.962

3.  T lymphocytes in patients with Down's syndrome.

Authors:  K Wisniewski; J M Cobill; C B Wilcox; E A Caspary; D G Williams; H M Wisniewski
Journal:  Biol Psychiatry       Date:  1979-06       Impact factor: 13.382

4.  Alzheimer's disease, trisomy 21, and myeloproliferative disorders: associations suggesting a genetic diathesis.

Authors:  L L Heston
Journal:  Science       Date:  1977-04-15       Impact factor: 47.728

5.  Presenile dementia in Down's syndrome. Ultrastructural identity with Alzheimer's disease.

Authors:  W G Ellis; J R McCulloch; C L Corley
Journal:  Neurology       Date:  1974-02       Impact factor: 9.910

6.  Antiviral and anticellular activities of human and murine type I and type II interferons in human cells monosomic, disomic, and trisomic for chromosome 21.

Authors:  Z X Zhang; E De Clercq; H Heremans; M Verhaegen-Lewalle; J Content
Journal:  Proc Soc Exp Biol Med       Date:  1982-05

7.  Human chromosome 21 dosage: effect on the expression of the interferon induced antiviral state.

Authors:  Y H Tan; E L Schneider; J Tischfield; C J Epstein; F H Ruddle
Journal:  Science       Date:  1974-10-04       Impact factor: 47.728

8.  Responsiveness of human cells trisomic for chromosome 21 to the antiviral action of human immune interferon.

Authors:  M De Ley; A Billiau
Journal:  Antiviral Res       Date:  1982-05       Impact factor: 5.970

9.  The development of the pathologic changes of Alzheimer's disease and senile dementia in patients with Down's syndrome.

Authors:  P C Burger; F S Vogel
Journal:  Am J Pathol       Date:  1973-11       Impact factor: 4.307

10.  Subregional localization of the gene(s) governing the human interferon induced antiviral state in man.

Authors:  Y H Tan; A E Greene
Journal:  J Gen Virol       Date:  1976-07       Impact factor: 3.891

View more
  2 in total

1.  Absence of the 40-kDa form of (2'-5')oligoadenylate synthetase and its corresponding mRNA from skin fibroblasts derived from Alzheimer disease patients.

Authors:  K K Khanna; S J An; J M Wu; S Landolfo; A G Hovanessian
Journal:  Proc Natl Acad Sci U S A       Date:  1991-07-01       Impact factor: 11.205

2.  Influenza virus non-structural protein 1 (NS1) disrupts interferon signaling.

Authors:  Danlin Jia; Ramtin Rahbar; Renee W Y Chan; Suki M Y Lee; Michael C W Chan; Ben Xuhao Wang; Darren P Baker; Bing Sun; J S Malik Peiris; John M Nicholls; Eleanor N Fish
Journal:  PLoS One       Date:  2010-11-10       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.